Project #3: Zona Pellucida Binding Proteins In Sperm Egg Interactions Reproduction is a complex and multifactorial process, and hundreds of mammalian genes have already been identified to function in reproduction. The binding of spermatozoa to the cumulus oophorus, the egg zona pellucida, and eventually the egg plasma membrane are essential steps for the future fusion of gamete genomes and the initiation of the zygote organization. As might be expected, both sperm and egg proteins play active roles in the initial and subsequent interactions of sperm and eggs. Many of the proteins that play key or supporting roles from binding of sperm to the zona pellucida until entry of the sperm DNA into the egg cytoplasm are largely unknown. Our overlying hypothesis is that the two zona pellucida binding proteins are critical mammalian sperm proteins in one or more of these steps in fertilization.
The Specific Aims are: 1) Study ZPBP1:ZPBP2 binding and sperm-egg interactions in vitro;2) Generate and analyze mice lacking ZPBP1, ZPBP2, or both;and 3) Determine whether men with defective binding of their sperm to eggs have mutations in ZPBP1 or ZPBP2 genes or additional candidate genes. These studies will be important for understanding the key proteins and mechanisms involved in sperm:egg interactions in vivo and will help to define essential proteins implicated in human male infertility.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Program Projects (P01)
Project #
5P01HD036289-10
Application #
8102880
Study Section
Special Emphasis Panel (ZHD1)
Project Start
Project End
2012-09-30
Budget Start
2010-04-01
Budget End
2012-09-30
Support Year
10
Fiscal Year
2010
Total Cost
$185,975
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Jorgez, Carolina J; Wilken, Nathan; Addai, Josephine B et al. (2015) Genomic and genetic variation in E2F transcription factor-1 in men with nonobstructive azoospermia. Fertil Steril 103:44-52.e1
Eisenberg, M L; Li, S; Herder, D et al. (2015) Testosterone therapy and mortality risk. Int J Impot Res 27:46-8
Carrell, D T; Nyboe Andersen, A; Lamb, D J (2015) The need to improve patient care through discriminate use of intracytoplasmic sperm injection (ICSI) and improved understanding of spermatozoa, oocyte and embryo biology. Andrology 3:143-6
Garcia, Jose M; Chen, Ji-an; Guillory, Bobby et al. (2015) Ghrelin Prevents Cisplatin-Induced Testicular Damage by Facilitating Repair of DNA Double Strand Breaks Through Activation of p53 in Mice. Biol Reprod 93:24
Gomez, Lissette; Kovac, Jason R; Lamb, Dolores J (2015) CYP17A1 inhibitors in castration-resistant prostate cancer. Steroids 95:80-7
Eisenberg, Michael L; Li, Shufeng; Betts, Paul et al. (2015) Testosterone therapy and cancer risk. BJU Int 115:317-21
Eisenberg, Michael L; Li, Shufeng; Behr, Barry et al. (2014) Semen quality, infertility and mortality in the USA. Hum Reprod 29:1567-74
Kovac, Jason R; Rajanahally, Saneal; Smith, Ryan P et al. (2014) Patient satisfaction with testosterone replacement therapies: the reasons behind the choices. J Sex Med 11:553-62
Kovac, Jason R; Pan, Michael M; Lipshultz, Larry I et al. (2014) Current state of practice regarding testosterone supplementation therapy in men with prostate cancer. Steroids 89:27-32
Kovac, Jason R; Kovac, Jason; Pastuszak, Alexander W et al. (2014) Testosterone supplementation therapy in the treatment of patients with metabolic syndrome. Postgrad Med 126:149-56

Showing the most recent 10 out of 72 publications